Thinking about buying stock in Canopy Growth, Lithium Americas, T2 Biosystems, Taysha Gene Therapies, or Archer Aviation?

Sorrento Therapeutics Inc

Change company Symbol lookup

Select an option...

SRNEQ Sorrento Therapeutics Inc

SPI SPI Energy Co Ltd

AMC AMC Entertainment Holdings Inc

BOF BranchOut Food Inc

KITT Nauticus Robotics Inc

EAT Brinker International Inc

JCSE JE Cleantech Holdings Ltd

GVP GSE Systems Inc

CURV Torrid Holdings Inc

APRN Blue Apron Holdings Inc

Health Care : Biotechnology | Small Cap Value

Company profile

Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next-generation of cancer therapeutics. The Scilex segment is organized around its non-opioid pain management operations and clinical pipeline. The Company’s immuno-oncology platforms, including its fully human antibodies (G-MAB library), ACEA small molecule library, immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs) and oncolytic virus (Seprehvec). The Company is also developing potential antiviral therapies against COVID-19, including FUJOVEE (Abivertinib) and its rapid diagnostic test, including COVIMARK.

Thinking about buying stock in Canopy Growth, Lithium Americas, T2 Biosystems, Taysha Gene Therapies, or Archer Aviation?

9:31 am ET September 18, 2023 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for CGC, LAC, TTOO, TSHA, and ACHR.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

-- CGC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CGC&prnumber=091820235

-- LAC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=LAC&prnumber=091820235

-- TTOO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TTOO&prnumber=091820235

-- TSHA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TSHA&prnumber=091820235

-- ACHR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ACHR&prnumber=091820235

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG12483&sd=2023-09-18

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-canopy-growth-lithium-americas-t2-biosystems-taysha-gene-therapies-or-archer-aviation-301930443.html

SOURCE InvestorsObserver

https://rt.newswire.ca/rt.gif?NewsItemId=CG12483&Transmission_Id=202309180931PR_NEWS_USPR_____CG12483&DateId=20230918

COMTEX_440443599/1005/2023-09-18T09:31:39